Despite the rising popularity of the minimally invasive laparoscopic option, open nephron-sparing surgery is still seen by many experts as the 'gold standard' for open surgery for kidney tumors and should remain the first choice for many patients. This challenges the idea that less-invasive therapies are always more desirable than open surgery. Whi

**Selected for Doody's Core Titles® 2024 with "Essential Purchase" designation in Oncology** Find oncology information fast with this concise, all-in-one clinical reference! Mosby's Oncology Nursing Advisor, 3rd Edition uses a streamlined format to provide quick access to the most essential information on oncology nursing care. Evidence-based guidelines include topics such as the major cancers, principles of cancer management, and principles of symptom management, as well as oncologic emergencies, palliative care, and nursing practice considerations. This edition includes new information on cancer treatments, genetic risk, chemotherapy guidelines, and more. Written by a team of oncology nursing experts led by Susan Maloney-Newton, this book is ideal for use in any oncology nursing setting. - Detailed descriptions of more than 50 major cancer types provide essential information on incidence, etiology and risk factors, signs and symptoms, diagnostic workup, histology, staging, treatment, prognosis, and prevention. - Coverage of cancer management principles outlines a wide range of treatment and pharmacologic modalities, including surgery, chemotherapy, radiation therapy, hormonal therapy, immunotherapy, and complementary and alternative therapies. - Symptom management guidelines offer in-depth coverage of pathophysiology, signs and symptoms, assessment tools, lab and diagnostic tests, differential diagnoses, interventions, patient education, follow up care, and resources for more than 30 common symptoms associated with cancer and cancer treatments. - Essential information on oncologic emergencies and emergent issues prepares readers to respond quickly to structural, urologic, metabolic, and hematologic emergencies. - Section on palliative care and end-of-life issues offers helpful guidelines for dealing with topics related to survivorship, palliative care, the final hours of the cancer patient, and loss, grief, and bereavement. - NEW! Updated content reflects the latest evidence-based information, including cancer biology, cancer treatment modalities, the latest chemotherapy guidelines, and a stronger emphasis on oral agents. - NEW! New content addresses the concept of "previvorship," the concept of coping with a documented genetically linked high cancer risk. - NEW! Enhanced content on health disparities, diversity and inclusion, and transgender considerations equips oncology nurses with essential information to promote health equity. - NEW! Key recommendations of the 2020-2030 Future of Nursing Report are integrated into the Nursing Practice Considerations section. - NEW! Content on the impact of the COVID pandemic includes delayed diagnosis and treatment and the impact of COVID sequelae on the health of patients with cancer. - NEW! Added content on palliative care is included in an expanded Pain chapter. - NEW! Full-color design and additional illustrations make it easier to use the book and to understand concepts. - NEW! Pulmonary Symptoms chapter now includes cough, dyspnea, and pleural effusion content.

A practical guide to methods of survival analysis for medical researchers with limited statistical experience. Methods and techniques described range from descriptive and exploratory analysis to multivariate regression methods. Uses illustrative data from actual clinical trials and observational studies to describe methods of analysing and reporting results. Also reviews the features and performance of statistical software available for applying the methods of analysis discussed.

Knowledge in the field of urologic pathology is growing at an explosive pace. Today’s pathologists, specialists, and residents require a comprehensive and authoritative text that examines the full range of urological diseases and their diagnosis. Written by recognized leaders and educators in the field, the text provides readers with a detailed understanding of all diagnostic aspects of urological disease. Inside this unique resource, readers will explore a broad spectrum of practical information—including etiology, diagnostic criteria, molecular markers, differential diagnosis, ancillary tests, and clinical management. This is sure to be the new definitive text for urological pathology!

Kidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, Onco-Nephrology provides authoritative, definitive coverage of the mechanism and management of these two life-threatening diseases. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed. - Addresses acute and chronic kidney diseases that develop from a variety of cancers. This includes direct kidney injury from the malignancy, paraneoplastic effects of the cancer, and various cancer agents used to treat the malignancy. - Discusses key issues regarding kidney disease in patients with cancer, including conventional chemotherapeutic regimens and new novel therapies (targeted agents and immunotherapies) or the malignancies themselves that may promote kidney injury; patients with chronic kidney disease who acquire cancer unrelated to renal failure; and kidney transplantation, which has been shown to carry an increased risk of cancer. - Contains dedicated chapters for each class of the conventional chemotherapeutic agents, targeted cancer agents, and cancer immunotherapies including the basic science, pathogenic mechanisms of injury, clinical manifestations, and treatment. - Includes special chapters devoted to the individual classes of chemotherapies that relate to kidney disease for quick reference. Discusses increasingly complex problems due to more numerous and specialized anti-cancer drugs, as well as increased survival rates for both cancer and renal failure requiring long-term patient care. - Covers anti-VEGF (antivascular endothelial growth factor) agents and cancer immunotherapies – treatments that are being recognized for adverse kidney effects. - Utilizes a clear, logical format based on the ASN Core Curriculum for Onco-Nephrology, making this reference an excellent tool for board review, as well as a practical resource in daily practice. - Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.